相关实验视频
Updated: Jan 15, 2026
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
11.1K
调整胰岛素受体信号使用新设计的激动剂
Xinru Wang1, Sarah Cardoso2, Kai Cai3
1Department of Biochemistry, University of Washington, Seattle, WA, USA; Institute for Protein Design, University of Washington, Seattle, WA, USA.
Molecular cell
|October 14, 2025
概括
科学家们设计了合成胰岛素受体 (IR) 激动剂,可触发不同的细胞反应. 这些新型激动剂显示出更好的降血糖,并避免癌细胞增殖,为代谢性疾病提供潜在的治疗益处.
科学领域:
- 生物化学和分子生物学
- 药理学 药理学是指药理学的学科.
- 蛋白质工程是指蛋白质工程.
背景情况:
- 胰岛素与胰岛素受体 (IR) 结合会引发形状变化,激活像AKT和MAPK这样的下游信号通路,这些通路调节了重要的细胞过程,如新陈代谢和增殖.
- 了解红外形状动态和下游信号之间的精确关系是开发向治疗的关键.
研究的目的:
- 设计新型合成激动剂,诱导胰岛素受体 (IR) 的特定形状变化.
- 调查不同的IR形态如何转化为不同的下游信号结果.
- 与胰岛素相比,开发潜在的代谢和增殖性疾病治疗药物,其疗效和安全性比胰岛素更好.
主要方法:
- 利用 de novo 蛋白质设计来创建向胰岛素受体单个细胞外域的结合剂.
- 通过将这些结合剂融合在各种方向和不同形状灵活性中,制造出合成的红外激素激活剂.
- 评估了受体自化,MAPK通路激活,受体贩运和细胞增殖,以应对合成激动剂.
- 在体内评估的降糖效应和对与疾病相关的IR突变体的活性.
主要成果:
- 产生了一系列合成红外激应激剂,能够引起广泛的下游反应.
- 确定了表现出比胰岛素更强效的激动剂,在体内实现了长时间的葡萄糖降低.
- 观察到与疾病相关的胰岛素受体突变的保留活性.
- 证明某些合成激动剂在很大程度上避免了通常由胰岛素诱导的癌细胞增殖.
结论:
- 这项研究阐明了胰岛素受体构成,动态和下游信号之间的复杂联系.
- 设计的合成激动剂为代谢和生殖障碍的治疗干预提供了一个有希望的途径.
- 这些新型激动剂为胰岛素提供了潜在的更安全的替代品,其疗效提高,并减少了癌细胞增殖等副作用.
相关概念视频
01:28Insulin: The Receptor and Signaling Pathways
2.8K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.8K
01:24Glucagon-like Receptor Agonists
841
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
841
01:30Spare Receptors
4.5K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
4.5K
01:25Drug-Receptor Interaction: Agonist
4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K